Raina Biosciences Inc. (Raina), an mRNA technology and therapeutics company, has released data from its generative AI platform in Science. The data supports Raina's pioneering approach to mRNA design ...

– GEMORNA is world’s first generative AI platform purpose-built for mRNA design and optimization, demonstrating state-of-the-art performance across diverse mRNA therapeutic applications – – GEMORNA ...

HYDERABAD, India & SAN FRANCISCO--(BUSINESS WIRE)--PopVax, an Indian full-stack biotechnology company developing broadly-protective mRNA vaccines using machine learning-enabled computational protein ...

The "mRNA Platform - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for mRNA Platform was estimated at US$152.0 Billion in 2024 and is ...

In the years after the 2020 COVID-19 pandemic, it is clear that mRNA as a modality for vaccines and therapeutics is here to stay based on the number of mRNA programs currently in clinical development.

Raina Biosciences published data from its generative AI platform in a study, “Deep generative models design mRNA sequences with enhanced translational capacity and stability,” recently published in ...